Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Integer Holdings Corporation Common Stock (NY:ITGR)

108.40 -4.53 (-4.01%)
Streaming Delayed Price Updated: 1:54 PM EDT, Apr 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Integer Holdings Corporation Common Stock

< Previous 1 2 3 Next >
Medical Devices & Supplies - Specialty Stocks Q3 Recap: Benchmarking STAAR Surgical (NASDAQ:STAA)
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - specialty industry, including STAAR Surgical... 
Via StockStory
Q4 Earnings Roundup: Bausch + Lomb (NYSE:BLCO) And The Rest Of The Medical Devices & Supplies - Specialty Segment
Looking back on medical devices & supplies - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Bausch + Lomb (NYSE:BLCO) and its peers. 
Via StockStory
Q4 Earnings Highs And Lows: Haemonetics (NYSE:HAE) Vs The Rest Of The Medical Devices & Supplies - Specialty Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Haemonetics (NYSE:HAE) and the best and... 
Via StockStory
Demystifying Integer Holdings: Insights From 5 Analyst Reviews
Via Benzinga
Earnings Scheduled For February 20, 2025
Via Benzinga
Beyond The Numbers: 4 Analysts Discuss Integer Holdings Stock
Via Benzinga
Decoding 11 Analyst Evaluations For Integer Holdings
Via Benzinga
This Merit Medical Systems Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Via Benzinga
A Look Back at Medical Devices & Supplies - Specialty Stocks’ Q3 Earnings: STAAR Surgical (NASDAQ:STAA) Vs The Rest Of The Pack
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at STAAR Surgical (NASDAQ:STAA) and the best... 
Via StockStory
Integer Holdings (NYSE:ITGR) Posts Better-Than-Expected Sales In Q4, Full-Year Outlook Slightly Exceeds Expectations
Medical technology company Integer Holdings (NYSE:ITGR) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 11.1% year on year to $449.5 million. The company’s full-year revenue... 
Via StockStory
Earnings To Watch: Integer Holdings (ITGR) Reports Q4 Results Tomorrow
Medical technology company Integer Holdings (NYSE:ITGR) will be announcing earnings results tomorrow before market hours. Here’s what you need to know. 
Via StockStory
Analyst Scoreboard: 8 Ratings For Integer Holdings
Via Benzinga
What 8 Analyst Ratings Have To Say About Integer Holdings
Via Benzinga
Navigating 6 Analyst Ratings For Integer Holdings
Via Benzinga
5 Analysts Have This To Say About Integer Holdings
Via Benzinga
ITGR Stock Earnings: Integer Holdings Beats EPS, Misses Revenue for Q2 2024
ITGR stock results show that Integer Holdings beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
How Esther Takeuchi Gave Heart Patients A New Lease On Life
Esther Takeuchi tackled a tough first project after joining private company Greatbatch. 
Via Investor's Business Daily
Integer Holdings Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
Via Benzinga
Integer Can Drive Consolidation Of Medical Device Outsourcing, Bullish Analyst Projects
Truist Securities initiates coverage on Integer. With a Buy rating and a $137 target, Integer is poised for significant gains driven by organic growth and strategic acquisitions. 
Via Benzinga
Beyond The Numbers: 7 Analysts Discuss Integer Holdings Stock
Via Benzinga
Integer Holdings Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
Via Benzinga
The Latest Analyst Ratings For Integer Holdings
Via Benzinga
Earnings Scheduled For February 15, 2024
Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million. 
Via Benzinga
Where Integer Holdings Stands With Analysts
Via Benzinga
ITGR Stock Earnings: Integer Holdings Beats EPS, Beats Revenue for Q1 2024
ITGR stock results show that Integer Holdings beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Medical Device Manufacture Integer To Gain From Expanding Pulsed Field Ablation Market, Earns Upgrade From BofA
BofA Securities' upgrades Integer, highlighting the growth potential of pulsed field ablation (PFA) in atrial fibrillation treatment. With projections of PFA sales skyrocketing from $100-200 million in... 
Via Benzinga
Topics Supply Chain
Exposures Supply Chain
Dexcom Stock Shows Market Leadership, Gets Rating Upgrade. Prognosis Good.
Among its other key ratings Dexcom has a near-best 98 Earnings Per Share Rating out of 99, reflecting strong profit growth this past year. 
Via Investor's Business Daily
Edwards Lifesciences Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark
The Relative Strength (RS) Rating for Edwards Lifesciences stock jumped into a new percentile Tuesday, with a rise from 78 to 81. 
Via Investor's Business Daily
Tandem Diabetes Care Stock Belongs On Your Watchlist As RS Rating Jump Higher
On Monday, Tandem Diabetes Care stock received an upgrade to its Relative Strength (RS) Rating, from 68 to 78. 
Via Investor's Business Daily
IBM, ServiceNow, Lennox, Morningstar And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded lower, with the Nasdaq Composite falling more than 90 points on Thursday. Here are some big stocks bucking the trend and recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.